<DOC>
	<DOCNO>NCT00129233</DOCNO>
	<brief_summary>Various guideline recommend angiotensin convert enzyme ( ACE ) inhibitor angiotensin â…¡ receptor-1 blocker ( ARBs ) hypertensive patient diabetes basis cardiac- reno-protective effect drug . However , recommendation could extrapolate Japanese patient , Japan know country low incidence coronary artery disease high incidence cerebrovascular disease . Furthermore , calcium channel blocker ( CCBs ) also protective renal function well ACE inhibitor Japanese diabetic hypertensive patient . This study test whether ARBs CCBs superior treat Japanese diabetic hypertensive patient .</brief_summary>
	<brief_title>Comparison Valsartan With Amlodipine Hypertensive Patients With Glucose Intolerance</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Clinical diagnosis hypertension Clinical diagnosis type 2 diabetes impair glucose tolerance History congestive heart failure , myocardial infarction , coronary revascularization recent 6 month . Taking calcium channel blocker purpose angina pectoris Reduced ejection fraction ( &lt; 40 % ) Second thirddegree atrioventricular block Severe hypertension ( &gt; 200/110 mmHg ) secondary hypertension History stroke recent 6 month Serum creatinine &gt; 2.5 mg/dl Estimated survival duration le 3 year due condition Pregnant woman possibly pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>cardiovascular disease</keyword>
	<keyword>rennin-angiotensin system</keyword>
	<keyword>calcium channel blocker</keyword>
	<keyword>impaired glucose tolerance</keyword>
</DOC>